NASDAQ:ARGX
argenx SE Stock News
$377.77
+11.43 (+3.12%)
At Close: May 29, 2024
Argenx Se (ARGX) Received its Third Buy in a Row
05:12am, Wednesday, 04'th Mar 2020
After Merrill Lynch and Guggenheim gave Argenx Se (NASDAQ: ARGX) a Buy rating last month, the company received another Buy, this time from Cowen & Co.
Argenx Se (ARGX) Received its Third Buy in a Row
05:11am, Wednesday, 04'th Mar 2020
After Merrill Lynch and Guggenheim gave Argenx Se (NASDAQ: ARGX) a Buy rating last month, the company received another Buy,
Wall Street Analysts Are Bullish on Top Healthcare Picks
07:02pm, Thursday, 27'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX) and Momenta Pharma (MNTA) with bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
07:02pm, Thursday, 27'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se
Top Ranked Momentum Stocks to Buy for February 27th
01:09pm, Thursday, 27'th Feb 2020
Top Ranked Momentum Stocks to Buy for February 27th
Top Ranked Momentum Stocks to Buy for February 27th
01:09pm, Thursday, 27'th Feb 2020
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 27th
argenx reports full year 2019 financial results and provides fourth quarter business update
06:00am, Thursday, 27'th Feb 2020
Topline data from Phase 3 ADAPT trial of efgartigimod in gMG expected in mid-2020Continued progress across broadest FcRn antagonist pipeline with up to five.
Our Take On argenx SE's (EBR:ARGX) CEO Salary
08:01am, Sunday, 09'th Feb 2020
In 2008 Tim Van Hauwermeiren was appointed CEO of argenx SE (EBR:ARGX). First, this article will compare CEO...
Head to Head Comparison: argenx (NASDAQ:ARGX) & PDL BioPharma (NASDAQ:PDLI)
10:08am, Sunday, 19'th Jan 2020
PDL BioPharma (NASDAQ:PDLI) and argenx (NASDAQ:ARGX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst
These 3 Healthcare Stocks Are Set to Soar in 2020, Says Cowen
01:40pm, Tuesday, 07'th Jan 2020
The calendar might have flipped to 2020, but that doesn’t mean everything has changed. Investors are still scouring the Street in search of the most compelling investment opportunities, the names th
Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus
02:40am, Monday, 30'th Dec 2019
Biotech stocks advanced in the penultimate week of the year, and the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) is on track to end the year with gains in excess of 25%. The previous week saw FD
Hedge Funds Are Warming Up To argenx SE (ARGX)
01:02pm, Saturday, 07'th Dec 2019
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 of 2018 due to various reasons. Nevertheless, the d
3 “Strong Buy” Biotech Stocks to Watch After Stifel Healthcare Conference
08:22pm, Friday, 22'nd Nov 2019
Are you prone to sudden surges of joy, abruptly followed by sinking bouts of misery? Do you react disproportionately to good or bad news? Well then, you might just be a biotech stock.Known for extreme
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceutica
